First Mercantile Trust’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

First Mercantile Trust’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$56K	Sell	403 -283	-41%	-$35.3K	0.01%	767
2021 Q2	$67K	Sell	686 -917	-57%	-$74.4K	0.01%	768
2021 Q1	$110K	Sell	1,603 -189	-11%	-$15.3K	0.01%	651
2020 Q4	$154K	Sell	1,792 -148	-8%	-$12.5K	0.02%	534
2020 Q3	$158K	Sell	1,940 -205	-10%	-$13.4K	0.02%	508
2020 Q2	$157K	Buy	+2,145	New	+$114K	0.02%	500
2020 Q1	–	Sell	-3,938	Closed	-$214K	–	938
2019 Q4	$214K	Buy	3,938 +396	+11%	+$19.6K	0.02%	436
2019 Q3	$148K	Buy	+3,542	New	+$150K	0.02%	582

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Mercantile Trust's BHVN Position: Q3 2021 in Review

First Mercantile Trust reduced its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 41% in Q3 2021, selling an estimated $35.3K and leaving 403 shares worth $56K. The position accounts for 0.01% of the portfolio, ranked #767.

First Mercantile Trust first reported a position in BHVN in Q3 2019 and has held it in 8 quarters since. The position peaked at $214K in Q4 2019. 249 funds tracked by Wall St. Rank hold BHVN as of Q3 2021.

First Mercantile Trust held 403 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $56K as of Q3 2021.
First Mercantile Trust sold 283 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2021, an estimated $35.3K.
Biohaven Pharmaceutical Holding Company Ltd. made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #767 holding.
First Mercantile Trust first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019 and has held it in 8 quarters since.
First Mercantile Trust's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $214K in Q4 2019.
249 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.